JavaScript is disabled in your browser. Please enable JavaScript to view this website.

DHODH

Function

Catalyzes the conversion of dihydroorotate to orotate with quinone as electron acceptor. Required for UMP biosynthesis via de novo pathway.

Involvement in disease

Postaxial acrofacial dysostosis

POADS

POADS is characterized by severe micrognathia, cleft lip and/or palate, hypoplasia or aplasia of the posterior elements of the limbs, coloboma of the eyelids and supernumerary nipples. POADS is a very rare disorder: only 2 multiplex families, each consisting of 2 affected siblings born to unaffected, nonconsanguineous parents, have been described among a total of around 30 reported cases.

None

The disease is caused by variants affecting the gene represented in this entry.

Pathway

Pyrimidine metabolism; UMP biosynthesis via de novo pathway; orotate from (S)-dihydroorotate (quinone route): step 1/1.

Post-translational modifications

The uncleaved transit peptide is required for mitochondrial targeting and proper membrane integration.

Sequence Similarities

Belongs to the dihydroorotate dehydrogenase family. Type 2 subfamily.

Cellular localization

Alternative names

DHOdehase, Dihydroorotate oxidase, DHODH

swissprot:Q02127 entrezGene:1723 omim:126064